miR146a impairs the IFN-induced anti-HBV immune response by downregulating STAT1 in hepatocytes

Liver International

Volumn 34, Issue 1, 2014, Pages 58-68

  Hou, Zhao H ^a   Han, Qiu J ^a   Zhang, Cai ^a   Tian, Zhi G ^a   Zhang, Jian ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

HBV; Innate immunity; MiR146a; STAT1; Type I interferon

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; MESSENGER RNA; MICRORNA 146A; RECOMBINANT ALPHA2A INTERFERON; STAT1 PROTEIN; VIRUS DNA; VIRUS RNA;

ARTICLE; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS B; IMMUNE RESPONSE; IN VITRO STUDY; LIVER CELL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; VIRUS LOAD; WESTERN BLOTTING;

HBV; INNATE IMMUNITY; MIR146A; STAT1; TYPE I INTERFERON;

ANTIVIRAL AGENTS; BINDING SITES; DOWN-REGULATION; DRUG RESISTANCE, VIRAL; HEP G2 CELLS; HEPATITIS B VIRUS; HEPATOCYTES; HOST-PATHOGEN INTERACTIONS; HUMANS; INTERFERON-ALPHA; MICRORNAS; PROMOTER REGIONS, GENETIC; RECOMBINANT PROTEINS; RNA INTERFERENCE; STAT1 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 84890128358     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12244     Document Type: Article

References (39)

1. Seeger C, Mason WS. Hepatitis B virus biology. Microbiol Mol Biol Rev 2000; 64: 51-68.
2. Lee WM. Hepatitis B virus infection. N Engl J Med 1997; 337: 1733-45.
3. Vierling JM. The immunology of hepatitis B. Clin Liver Dis 2007; 11: 727-59.
4. Chang KM. Hepatitis B immunology for clinicians. Clin Liver Dis 2010; 14: 409-24.
5. Bhattacharya D, Thio CL. Review of hepatitis B therapeutics. Clin Infect Dis 2010; 51: 1201-8.
6. Pestka S, Krause CD, Walter MR. Interferons, interferon-like cytokines, and their receptors. Immunol Rev 2004; 202: 8-32.
7. Kao JH. Appropriate use of interferon for treatment of chronic hepatitis B. Hepatol Res 2007; 37: S47-54.
8. Perrillo R. Benefits and risks of interferon therapy for hepatitis B. Hepatology 2009; 49 (5 Suppl): S103-11.
9. Hadziyannis SJ. Milestones and perspectives in viral hepatitis B. Liver Int 2011; 31(Suppl 1): 129-34.
10. Thai H, Campo DS, Lara J, et al. Convergence and coevolution of hepatitis B virus drug resistance. Nat Commun 2012; 3: 789.
11. Shruti K, Shrey K, Vibha R. Micro RNAs: tiny sequences with enormous potential. Biochem Biophys Res Commun 2011; 407: 445-9.
12. Roberts AP, Lewis AP, Jopling CL. The role of microRNAs in viral infection. Prog Mol Biol Transl Sci 2011; 102: 101-39.
13. Stern-Ginossar N, Elefant N, Zimmermann A, et al. Host immune system gene targeting by a viral miRNA. Science 2007; 317: 376-81.
14. Lecellier CH, Dunoyer P, Arar K, et al. A cellular microRNA mediates antiviral defense in human cells. Science 2005; 308: 557-60.
15. Tsitsiou E, Lindsay MA. microRNAs the immune response Curr Opin Pharmacol 2009; 9: 514-20.
16. Labbaye C, Testa U. The emerging role of MIR-146A in the control of hematopoiesis, immune function and cancer. J Hematol Oncol 2012; 5: 13.
17. Huang LR, Wu HL, Chen PJ, Chen DS. An immunocompetent mouse model for the tolerance of human chronic hepatitis B virus infection. Proc Natl Acad Sci U S A 2006; 103: 17862-7.
18. Taganov KD, Boldin MP, Chang KJ, Baltimore D. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A 2006; 103: 12481-6.
19. Tang Y, Luo X, Cui H, et al. MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum 2009; 60: 1065-75.
20. Su C, Hou Z, Zhang C, Tian Z, Zhang J. Ectopic expression of microRNA-155 enhances innate antiviral immunity against HBV infection in human hepatoma cells. Virol J 2011; 8: 354.
21. Han Q, Zhang C, Zhang J, Tian Z. Reversal of hepatitis B virus-induced immune tolerance by an immunostimulatory 3p-HBx-siRNAs in a retinoic acid inducible gene I-dependent manner. Hepatology 2011; 54: 1179-89.
22. Tobita K, Ohori K. Polypeptide analysis of hepatitis virus type B surface antigen produced by a human hepatoma cell line, PLC/PRF/5. Acta Virol 1980; 24: 367-70.
23. Cameron JE, Yin Q, Fewell C, et al. Epstein-Barr virus latent membrane protein 1 induces cellular MicroRNA miR-146a, a modulator of lymphocyte signaling pathways. J Virol 2008; 82: 1946-58.
24. Wei Y, Neuveut C, Tiollais P, Buendia MA. Molecular biology of the hepatitis B virus and role of the X gene. Pathol Biol (Paris) 2010; 58: 267-72.
25. O'shea JJ, Plenge R. JAK and STAT signaling molecules in immunoregulation and immune-mediated disease. Immunity 2012; 36: 542-50.
26. Lu LF, Boldin MP, Chaudhry A, et al. Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell 2010; 142: 914-29.
27. Wieland S, Thimme R, Purcell RH, Chisari FV. Genomic analysis of the host response to hepatitis B virus infection. Proc Natl Acad Sci U S A 2004; 101: 6669-74.
28. Lan P, Zhang C, Han Q, Zhang J, Tian Z. Therapeutic recovery of HBV-induced hepatocyte-intrinsic immune defect reverses systemic adaptive immune tolerance. Hepatology 2013; 58: 73-85.
29. Shi YH, Shi CH. Molecular characteristics and stages of chronic hepatitis B virus infection. World J Gastroenterol 2009; 15: 3099-105.
30. Grassmann R, Jeang KT. The roles of microRNAs in mammalian virus infection. Biochim Biophys Acta 2008; 1779: 706-11.
31. Chen XM. MicroRNA signatures in liver diseases. World J Gastroenterol 2009; 15: 1665-72.
32. Filipowicz W, Grosshans H. The liver-specific microRNA miR-122: biology and therapeutic potential. Prog Drug Res 2011; 67: 221-38.
33. Meraz MA, White JM, Sheehan KC, et al. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 1996; 84: 431-42.
34. Ding C, Wei H, Sun R, Zhang J, Tian Z. Hepatocytes proteomic alteration and seroproteome analysis of HBV-transgenic mice. Proteomics 2009; 9: 87-105.
35. Guo L, Yang X, Duan T. Altered microRNA expression profile in maternal and fetal liver of HBV transgenic mouse model. J Matern Fetal Neonatal Med 2012; 25: 2071-7.
36. Benhenda S, Cougot D, Buendia MA, Neuveut C. Hepatitis B virus X protein molecular functions and its role in virus life cycle and pathogenesis. Adv Cancer Res 2009; 103: 75-109.
37. Wang Y, Lu Y, Toh ST, et al. Lethal-7 is down-regulated by the hepatitis B virus x protein and targets signal transducer and activator of transcription 3. J Hepatol 2010; 53: 57-66.
38. Wu G, Yu F, Xiao Z, et al. Hepatitis B virus X protein downregulates expression of the miR-16 family in malignant hepatocytes in vitro. Br J Cancer 2011; 105: 146-53.
39. Machlin ES, Sarnow P, Sagan SM. Combating hepatitis C virus by targeting microRNA-122 using locked nucleic acids. Curr Gene Ther 2012; 12: 301-6.